Cancer‐related disease factors and smoking cessation treatment: Analysis of an ongoing clinical trial

E-ISSN： 1099-1611|27|2|471-476

ISSN： 1057-9249

Source： PSYCHO-ONCOLOGY (ELECTRONIC), Vol.27, Iss.2, 2018-02, pp. : 471-476

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of clinical trial design and execution-related factors on incidence of thromboembolic events in cancer patients: a systematic review and meta-analysis

By Reynolds Matthew W. Shibata Atsuko Zhao Sean Jones Natalie Fahrbach Kyle Goodnough Lawrence Tim

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 497-505

Informa Healthcare

Access to resources Recommend Favorite

Smoking Cessation: An Integral Part of Lung Cancer Treatment

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 289-301

Karger

Access to resources Recommend Favorite

Ongoing Clinical Trials in Testicular Cancer: The TIGER Trial

Oncology Research and Treatment, Vol. 39, Iss. 9, 2016-09 ,pp. : 553-556

Karger

Access to resources Recommend Favorite

Ongoing Clinical Trials in Prostate Cancer: The STAMPEDE Trial

Oncology Research and Treatment, Vol. 39, Iss. 7-8, 2016-07 ,pp. : 464-467

Karger

Access to resources Recommend Favorite

Social and cognitive factors contributing to the intention to undergo a smoking cessation treatment

By Van Der Rijt G.A.J. Westerik H.

Addictive Behaviors, Vol. 29, Iss. 1, 2004-01 ,pp. : 191-198

Elsevier

Access to resources Recommend Favorite